These results, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the strategy of targeting ACKR3 as a singular approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant Conditions. (3) Other than if the https://hanki624dik9.blogaritma.com/profile